The selection, screening, and assessment of the chosen studies were assisted by the remaining authors, AR and AFR. A further 239 records were subsequently removed during the full-text screening stage; seven articles were, thus, left for an in-depth examination. We provide a table that summarizes all the data gathered on the comparison of different factors linked to the ones previously discussed in order to improve comprehension of the data. Because it promotes protein synthesis and muscle hypertrophy through androgen receptor binding in muscle cells, testosterone is a critical regulator of muscle mass; this anabolic impact is required for muscle development and repair, making testosterone crucial for preserving muscle mass . Essential for bone maturation, testosterone helps bones reach maximal mass and preserves bone density, all during adulthood; it also promotes skeletal growth by improving mechanical loading . Libido, or sexual desire, is significantly influenced by testosterone, which regulates various brain regions involved in sexual motivation, including the hypothalamus; in men, testosterone plays a crucial role in sexual desire and arousal . DHT has a stronger androgenic effect and is essential for the maintenance of prostate health and the development of secondary sexual traits in men . In the event of substantial clinical, methodological or statistical heterogeneity, we will not report study results as the pooled effect estimate in a meta-analysis. Where standard deviations for outcomes are not reported, we will impute these values by assuming the standard deviation of the missing outcome to be the average of the standard deviations from those studies where this information was reported. Two review authors (RI, RB) will assess the risk of bias of each included study independently. Data will be extracted on the basic characteristics and outcomes of author/year, country/setting, study population, age, number of women randomised, intervention (placebo/treatment), duration and route of intervention, and different outcomes. Given its high sensitivity and specificity, LC-MS/MS has emerged as the preferred method for the quantification of steroid hormones in human serum 13,14. The AMR was 2.5–1000 ng/dL (0.09–34.7 nmol/L), requiring 0.5 mL of male serum and 1.0 mL of female serum. A reference laboratory in the United States reported a high-turbulence flow HPLC, with the online SPE method achieving an assay linear range of 2 to 2000 ng/dL and a LOQ of 0.3 ng/dL . Estimates for those studies could therefore not be included in the calculation of summary estimates and 95% CIs could not be calculated in forest plots. This was a key limitation of the analyses and likely to have resulted in an oversimplification of true effects. Linear models were fitted because the HR estimates were reported for insufficient numbers of testosterone categories to have fitted non-linear DR-MA models. However, DR-MA summary estimates demonstrated no significant effects of baseline testosterone on the relative hazard of death from any cause or from CVD, with negligible heterogeneity present. These results demonstrate no overall effect of baseline testosterone concentration on the relative hazard of death from CVD after adjusting for factors including age, smoking status, and BMI or waist circumference. These results demonstrate no overall effect of baseline testosterone concentration on the relative hazard of death from any cause after adjusting for factors including age, smoking status and BMI or waist circumference. A comparable HR was calculated from a CHAMP study article9 for inclusion in the forest plot but not in the DR-MA, because a corresponding estimate of variance per 5 nmol/L increase in testosterone could not be calculated. It is significant to emphasize that since this study reviews already published studies pertaining to patient data, ethical approval is not necessary. The likelihood of sarcopenia (age-related muscle loss) and diminished muscle strength rises as testosterone levels naturally fall with age; however, research indicates that testosterone therapy may mitigate these effects in older men, enhancing physical performance, sexual drive, and muscle mass . Descriptive, observational, and experimental studies including healthy men-more especially, those assessing the effects of testosterone therapy-were required for inclusion. The goal of this study was to assess the changes in prescribing patterns nationally to see if this reflected a larger trend. All of the data obtained was freely available on individual request from the following institutional points of contact, and data may be shared by these institutions on reasonable request and with the completion of a Data Use Agreement. Some of those agreements obligate us to destroy the data after publication, others prohibit the data from being shared without permission from the governing body, and some data does not have that restriction. The measurable range listed in the package insert is 13–1009 ng/dL (0.45–35 nmol/L). It is a competitive immunoassay using anti-testosterone monoclonal-antibody-coated microparticles and acridinium-labeled testosterone. The unbound and albumin-bound fractions together make up approximately 35% of testosterone and represent the bioavailable form . SHBG binds testosterone with very high affinity and albumin binds it with lower affinity. Most circulating testosterone is bound to sex hormone-binding globulin (SHBG) or albumin.
